Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00251615 · ClinicalTrials.gov registry record
Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 18
- Enrollment target
NCT00251615: Completed study, sponsored by National Institute on Aging (NIA).
NCT00251615 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00251615 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to learn what changes in blood vessel contraction may occur as a result of a disease of the vessel that requires surgery. The study will examine the calcium channels present in the vessels being operated on, and the genes that may alter blood vessel function. Possible variation in these genes may change the kind of calcium channels present in blood vessels.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-08 |
| Est. Completion | 2012-08 |
What the finished NCT00251615 record still lists
NCT00251615 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00251615 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00251615 about?
NCT00251615 is a clinical study titled "Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging". The purpose of this study is to learn what changes in blood vessel contraction may occur as a result of a disease of the vessel that requires surgery. The study will examine the calcium channels present in the vessels being operated on, and the genes that may alter blood vessel function. Possible va...
What is the current status of trial NCT00251615?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2012-08. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT00251615?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia